The Patent Finder

Pyridazinones as PARP7 Inhibitors (2019)

Ribon Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 62/664,544, filed Apr 30, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,550,105Pyridazinones as PARP7 Inhibitors
In force
 · High confidence
UsedRemaining
Ribon Therapeutics Inc.In forceHigh confidence
US 10,870,641Pyridazinones as PARP7 Inhibitors
In force
 · High confidence
Ribon Therapeutics, Inc.In forceHigh confidence
US 11,014,913Pyridazinones as PARP7 Inhibitors
In force
 · High confidence
Ribon Therapeutics, Inc.In forceHigh confidence
US 11,566,020Pyridazinones as PARP7 Inhibitors
In force
 · High confidence
Ribon Therapeutics, Inc.In forceHigh confidence
Application 17/974,830Pyridazinones as PARP7 Inhibitors
Abandoned
Abandoned May 20, 2024
Ribon Therapeutics, Inc.AbandonedAbandoned May 20, 2024
Application 18/613,601Pyridazinones as PARP7 Inhibitors
Pending
Not granted
Nerviano Medical Sciences, Inc.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Ribon Therapeutics, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited